Insider Transactions last 24 months for Vir Biotechnology, Inc.  -  NSDQ: VIR

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Sabatini BrentSVP, Chief Accounting Officer03/23/2026DSDirectCOM7,711$9.12$70,324.3261,902
O'Byrne JasonEVP & Chief Financial Officer03/20/2026AJIndirectCOM2,500$0.00$0.002,500
O'Byrne JasonEVP & Chief Financial Officer03/20/2026DJDirectCOM2,500$0.00$0.00160,115
Sato Vicki LDirector03/02/2026DSDirectCOM200$9.98$1,996.001,122,391
Sato Vicki LDirector03/02/2026DSDirectCOM21,800$9.50$207,185.021,122,591
De Verneuil VaninaEVP, General Counsel, Corp Sec02/25/2026DSDirectCOM13,700$9.82$134,534.00112,982
Eisner MarkEVP and Chief Medical Officer02/25/2026DSDirectCOM1,889$9.82$18,549.98154,024
De Backer MarianneChief Executive Officer02/24/2026DSDirectCOM14,762$9.53$140,720.241,020,704
De Verneuil VaninaEVP, General Counsel, Corp Sec02/24/2026DSDirectCOM3,117$9.53$29,713.11126,682
Eisner MarkEVP and Chief Medical Officer02/24/2026DSDirectCOM1,616$9.53$15,404.68155,913
O'Byrne JasonEVP & Chief Financial Officer02/24/2026DSDirectCOM1,634$9.53$15,576.27162,615
Sabatini BrentSVP, Chief Accounting Officer02/24/2026DSDirectCOM1,430$9.53$13,631.6269,613
Sato Vicki LDirector02/24/2026DSDirectCOM200$10.26$2,052.001,144,391
Sato Vicki LDirector02/24/2026DSDirectCOM42,177$9.75$411,314.321,144,591
Sato Vicki LDirector02/24/2026AMDirectCOM42,377$1.49$62,929.851,186,768
De Backer MarianneChief Executive Officer02/23/2026DSDirectCOM19,039$7.45$141,893.861,035,466
De Verneuil VaninaEVP, General Counsel, Corp Sec02/23/2026DSDirectCOM4,445$7.45$33,127.70129,799
Eisner MarkEVP and Chief Medical Officer02/23/2026DSDirectCOM2,089$7.45$15,568.90157,529
O'Byrne JasonEVP & Chief Financial Officer02/23/2026DSDirectCOM2,089$7.45$15,568.90164,249
Sabatini BrentSVP, Chief Accounting Officer02/23/2026DSDirectCOM1,829$7.45$13,631.1771,043
De Backer MarianneChief Executive Officer02/22/2026AADirectCOM285,000$0.00$0.001,054,505
De Verneuil VaninaEVP, General Counsel, Corp Sec02/22/2026AADirectCOM55,000$0.00$0.00134,244
Eisner MarkEVP and Chief Medical Officer02/22/2026AADirectCOM55,000$0.00$0.00159,618
O'Byrne JasonEVP & Chief Financial Officer02/22/2026AADirectCOM55,000$0.00$0.00166,338
Sabatini BrentSVP, Chief Accounting Officer02/22/2026AADirectCOM25,000$0.00$0.0072,872
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel